SJS Investment Consulting »

Recursion Pharmaceuticals shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2024-03-31 $997 100 9.97
2023-12-31 $986 100 9.86

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Hormel Foods Corporation (HRL)
Eli Lilly & Co. (LLY)
Dimensional Etf Trust Short Duration F (DFSD)
Apple (AAPL)
Dimensional Etf Trust World Ex Us Core (DFAX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Emerging Mkts Co (DFEM)

View all positions for SJS Investment Consulting

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals